Sandbox g21: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) |
Gerald Chi- (talk | contribs) |
||
Line 260: | Line 260: | ||
* [[Voriconazole]] | * [[Voriconazole]] | ||
* [[Zafirlukast]] | * [[Zafirlukast]] | ||
====CYP2C19 {{ID-returntotop}}==== | |||
* [[Cimetidine]] | |||
* [[Esomeprazole]] | |||
* [[Felbamate]] | |||
* [[Fluoxetine]] | |||
* [[Fluvoxamine]] | |||
* [[Indomethacin]] | |||
* [[Ketoconazole]] | |||
* [[Lansoprazole]] | |||
* [[Modafinil]] | |||
* [[Omeprazole]] | |||
* [[Oxcarbazepine]] | |||
* [[Pantoprazole]] | |||
* [[Probenecid]] | |||
* [[Rabeprazole]] | |||
* [[Ticlopidine]] | |||
* [[Topiramate]] | |||
}}</div> | }}</div> |
Revision as of 09:03, 5 June 2015
Substrates of Cytochrome P-450 Isozymes
The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
3Inhibitors of Cytochrome P-450 Isozymes
The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
3